Mains Practice Questions for the Day
- Q. India’s pharmaceutical sector is shifting from generic manufacturing to innovation-led growth. Discuss the opportunities and challenges in this transition. Suggest measures to make India a global pharmaceutical leader by 2030.
- Q. Zoonotic diseases are emerging as a defining public health challenge of the twenty-first century. Discuss in the context of ecological disruption, climate change and the need for a One Health approach.
Q. India’s pharmaceutical sector is shifting from generic manufacturing to innovation-led growth. Discuss the opportunities and challenges in this transition. Suggest measures to make India a global pharmaceutical leader by 2030.
(GS Paper III: Science and Technology, Industrial Growth and Health Security)
Introduction:
India’s Pharmaceutical Transition: Opportunities, Challenges and Way Forward
India’s pharmaceutical sector is moving from a low-cost generic manufacturing model to a science-led innovation model. The sector is valued at nearly $65 billion and supplies around 20% of the world’s generic medicines. India now aims to build a $130 billion pharmaceutical market by 2030. This transition is important for health security, industrial growth, export competitiveness and technological self-reliance.
Body
India’s Pharmaceutical Transition: Opportunities, Challenges and Way Forward
India’s pharmaceutical sector is moving from a low-cost generic manufacturing model to a science-led innovation model. The sector is valued at nearly $65 billion and supplies around 20% of the world’s generic medicines. India now aims to build a $130 billion pharmaceutical market by 2030. This transition is important for health security, industrial growth, export competitiveness and technological self-reliance.
Conclusion:
India’s pharmaceutical future depends on combining affordability with innovation. If India strengthens R&D, regulation, quality systems, API self-reliance and skilled human resources, it can become a trusted global pharmaceutical leader by 2030. This will support national health security, inclusive access to medicines and India’s larger goal of self-reliant development.
Q. Zoonotic diseases are emerging as a defining public health challenge of the twenty-first century. Discuss in the context of ecological disruption, climate change and the need for a One Health approach.
(GS Paper II –Governance, Public Health Systems, International Health Regulations)
Introduction:
India’s pharmaceutical future depends on combining affordability with innovation. If India strengthens R&D, regulation, quality systems, API self-reliance and skilled human resources, it can become a trusted global pharmaceutical leader by 2030. This will support national health security, inclusive access to medicines and India’s larger goal of self-reliant development.
Body
Ecological Disruption and Zoonotic Risk
Ecological disruption is a major driver of zoonotic spillovers.
- Deforestation brings humans closer to wildlife reservoirs such as bats and rodents.
- Agricultural expansion and unplanned urbanisation increase contact between humans, livestock and wild animals.
- Habitat fragmentation pushes animals into human settlements, farms and markets.
- Industrial livestock farming creates large populations of genetically similar animals, which can amplify pathogens.
Diseases such as Nipah and Ebola show how habitat loss can increase contact between humans and disease-carrying animals.
Climate Change and Disease Spread
Climate change is reshaping the geography of infectious diseases.
- Rising temperatures and changing rainfall patterns affect animal movement and breeding.
- Mosquitoes and ticks are expanding into new areas, including higher altitudes and latitudes.
- Changes in agriculture and land productivity influence rodent populations.
- Fragile health systems may fail to detect new outbreaks early.
Thus, climate change acts as a risk multiplier for zoonotic diseases.
Need for One Health Approach
A One Health approach recognises that human health, animal health and environmental health are interconnected.
It requires:
- Integrated surveillance of humans, animals and wildlife
- Environmental sampling and early warning systems
- Real-time data sharing
- Strong veterinary and public health systems
- Regulation of high-risk livestock practices
- Protection of forests and biodiversity
Conclusion:
Zoonotic diseases are not isolated accidents. They are linked to ecological damage, climate change and weak surveillance. The twenty-first century needs a preventive public health model based on One Health, ecological balance, climate resilience and global cooperation. Only such an integrated approach can reduce the risk of future pandemics.
